血清血管生成素样蛋白4、成纤维细胞生长因子-23水平与糖尿病肾病患者病情严重程度及预后的关系OACSTPCD
Relationships of serum angiopoietin-like protein 4 and fibroblast growth factor 23 levels with severity and prognosis of patients with diabetes nephropathy
目的 探讨血清血管生成素样蛋白4(ANGPTL4)、成纤维细胞生长因子-23(FGF-23)水平与糖尿病肾病患者病情严重程度及预后的关系.方法 选取2018年7月-2020年7月120例糖尿病肾病患者作为研究对象(糖尿病肾病组),根据糖尿病肾病分期标准分为轻症组62例与重症组58例;根据3年内预后情况分为预后良好组94例与预后不良组26例.选取102例糖尿病患者为单纯糖尿病组,81例健康体检志愿者作为对照组.采用酶联免疫吸附实验检测糖尿病肾病患者血清ANGPTL4、FGF-23水平.采用Logistic回归分析筛选患者预后的影响因素,绘制受试者工作特征(ROC)曲线,分析ANGPTL4、FGF-23及两者联合对糖尿病肾病患者病情严重程度及预后评估价值.结果 糖尿病肾病组及单纯糖尿病组的ANGPTL4、FGF-23水平高于对照组,差异有统计学意义(P<0.05);与单纯糖尿病组相比,糖尿病肾病组的ANGPTL4、FGF-23水平增加,差异有统计学意义(P<0.05);与轻症组相比,重症组的ANGPTL4、FGF-23水平增加,差异有统计学意义(P<0.05).ROC曲线对病情严重程度的评估发现,ANGPTL4、FGF-23以及二者联合诊断的曲线下面积(AUC)分别为0.748、0.781、0.858,联合诊断显著优于 FGF-23(Z=2.149,P=0.032)、ANGPTL4(Z=2.886,P=0.004)单独诊断;预后良好组的 ANGPTL4、FGF-23 水平与预后不良组相比显著降低(P<0.05);不同预后糖尿病肾病患者的糖尿病病程、血尿素氮(BUN)、血清肌酐(Scr)、空腹血糖(FBG)、糖化血红蛋白(HbA1C)、高血压以及ANGPTL4、FGF-23水平差异有统计学意义(P<0.05);Scr、ANGPTL4、FGF-23水平均为影响糖尿病肾病预后的危险因素(P<0.05);ROC曲线对患者预后评估发现,ANGPTL4、FGF-23以及二者联合诊断的 AUC 分别为 0.774、0.795、0.874,联合诊断显著优于 FGF-23(Z=2.385,P=0.171)、ANGPTL4(Z=2.317,P=0.021)单独诊断.结论 糖尿病肾病患者血清ANGPTL4、FGF-23水平显著升高,二者对糖尿病肾病患者的临床诊断及预后评估具有一定的参考价值.
Objective To investigate the relationships of serum angiopoietin-like protein 4(ANGPTL4)and fibroblast growth factor-23(FGF-23)levels with the severity and prognosis of patients with diabet-ic nephropathy.Methods A total of 120 patients(diabetic nephropathy group)with diabetic nephrop-athy were selected from July 2018 to July 2020 and divided into mild group(n=62)and severe group(n=58)according to the staging criteria of diabetic nephropathy;based on the prognosis within 3 years,they were also divided into good prognosis group(n=94)and poor prognosis group(n=26).Addition-ally,102 diabetic patients were enrolled as diabetic group,and 81 healthy volunteers were selected as control group.The serum levels of ANGPTL4 and FGF-23 in diabetic nephropathy patients were detected by enzyme-linked immunosorbent assay(ELISA).Logistic regression analysis was used to analyze the influencing factors of prognosis,and receiver operating characteristic(ROC)curves were drawn to ana-lyze the values of ANGPTL4,FGF-23 and their combination in assessing the severity and prognosis of diabetic nephropathy.Results The levels of ANGPTL4 and FGF-23 in the diabetic nephropathy group and simple diabetic group were significantly higher than those in the control group(P<0.05);compared with the simple diabetic group,the levels of ANGPTL4 and FGF-23 in the diabetic ne-phropathy group were significantly increased(P<0.05);the levels of ANGPTL4 and FGF-23 in the severe group were significantly higher than those in the mild group(P<0.05);the ROC curve analysis revealed that the areas under the curve(AUCs)for assessing disease severity of ANGPTL4,FGF-23 and their combination were 0.748,0.781 and 0.858 respectively,and the combined diagnosis was significantly better than FGF-23(Z=2.149,P=0.032)and ANGPTL4(Z=2.886,P=0.004)alone;the levels of ANGPTL4 and FGF-23 in the good prognosis group were significantly lower than those in the poor prognosis group(P<0.05);significant differences were observed in diabetes dura-tion,blood urea nitrogen(BUN),serum creatinine(Scr),fasting blood glucose(FBG),glycated hemoglobin(HbA1C),hypertension,ANGPTL4 and FGF-23 levels between diabetic nephropathy pa-tients with different prognoses(P<0.05);the Scr,ANGPTL4 and FGF-23 levels were all risk factors affecting the prognosis of diabetic nephropathy(P<0.05);the ROC curve analysis for prognosis as-sessment showed that the AUCs of ANGPTL4,FGF-23 and their combination were 0.774,0.795 and 0.874 respectively;the combined diagnosis was significantly better than FGF-23(Z=2.385,P=0.171)and ANGPTL4(Z=2.317,P=0.021)alone.Conclusion The serum levels of ANGPTL4 and FGF-23 are significantly increased in diabetic nephropathy patients,and they have certain refer-ence value for the clinical diagnosis and prognosis assessment of diabetic nephropathy patients.
胡乐乐;魏银宇;王金艳;朱坤良;刘国英
河北省沧州市中心血站,河北沧州,061000河北省沧州市中心医院,河北沧州,061000河北省泊头市医院,河北沧州,062150
临床医学
糖尿病肾病血管生成素样蛋白4成纤维细胞生长因子-23病情严重程度预后
diabetic nephropathyangiopoietin-like protein 4fibroblast growth factor-23severity of diseaseprognosis
《实用临床医药杂志》 2024 (018)
56-61 / 6
河北省医学科学研究课题计划项目(20220363)
评论